Trazodone Add-on in COVID-19-related Selective Serotonin Reuptake Inhibitor-resistant Post-traumatic Stress Disorder in Healthcare Workers: Two Case Reports

다국어 초록 (Multilingual Abstract)

COVID-19 represents a significant stress factor for all people worldwide due to several factors, including quarantine, lockdowns, fear of contagion, deaths, and other traumatic events. However, the healthcare workers (HCWs) have paid the higher price of this pandemic in terms of fatalities, contagions, and psychological well-being. Studies suggest that this particular population is at increased risk of developing a severe post-traumatic stress disorder (PTSD). The early diagnosis and timely treatment of PTSD in HCWs may restore well-being and significantly impact health services functioning, reducing burnout, days spent far from work, disrupted personal and team empowerment, and worse job performances. In the present article, we reported on two cases of HCWs directly involved in the treatment of COVID-19 patients who showed selective serotonin reuptake inhibitor-resistant PTSD, which was successfully treated with extended- release trazodone TRZ ContramidⓇ add-on.

참고문헌 (Reference)

1 Wichniak A, "[The effects of antidepressants on sleep in depressed patients with particular reference to trazodone in comparison to agomelatine, amitriptyline, doxepin, mianserine and mirtazapine]" 31 : 65-70, 2011

2 Mascarel P, "[Sleep disorders and their treatment in post-traumatic stress disorder]" 48 : 1051-1058, 2019

3 Cuomo A, "[Personalized medicine with extended-release trazodone and/or once-a-day trazodone : from research trials to clinical practice]" 55 : 255-261, 2020

4 Detweiler MB, "Treatment of post-traumatic stress disorder nightmares at a veterans affairs medical center" 5 : 117-, 2016

5 Horesh D, "Traumatic stress in the age of COVID-19 : a call to close critical gaps and adapt to new realities" 12 : 331-335, 2020

6 Giallonardo V, "The impact of quarantine and physical distancing following COVID-19 on mental health : study protocol of a multicentric Italian population trial" 11 : 533-, 2020

7 Maunder R, "The experience of the 2003 SARS outbreak as a traumatic stress among frontline healthcare workers in Toronto : lessons learned" 359 : 1117-1125, 2004

8 Kemal Tolga Saracoglu, "The Psychological Impact of COVID-19 Disease is more Severe on Intensive Care Unit Healthcare Providers: A Cross-sectional Study" 대한정신약물학회 18 (18): 607-615, 2020

9 Sema Ketenci, "The Neurochemical Effects of Prazosin Treatment on Fear Circuitry in a Rat Traumatic Stress Model" 대한정신약물학회 18 (18): 219-230, 2020

10 Pettersson A, "The Mini-International Neuropsychiatric Interview is useful and well accepted as part of the clinical assessment for depression and anxiety in primary care : a mixed-methods study" 19 : 19-, 2018

11 Ju-Wan Kim, "Telephone based Interventions for Psychological Problems in Hospital Isolated Patients with COVID-19" 대한정신약물학회 18 (18): 616-620, 2020

12 De Berardis D, "Targeting the noradrenergic system in posttraumatic stress disorder : a systematic review and metaanalysis of prazosin trials" 16 : 1094-1106, 2015

13 Warner MD, "Survey on the usefulness of trazodone in patients with PTSD with insomnia or nightmares" 34 : 128-131, 2001

14 López CM, "Residual insomnia and nightmares postintervention symptom reduction among veterans receiving treatment for Comorbid PTSD and depressive symptoms" 50 : 910-923, 2019

15 Maguire PA, "Reappraising prazosin for night-time symptoms in post-traumatic stress disorder" 54 : 848-849, 2020

16 Shi L, "Prevalence and correlates of symptoms of post-traumatic stress disorder among Chinese healthcare workers exposed to physical violence : a cross-sectional study" 7 : e016810-, 2017

17 Christopher Reist, "Prazosin for treatment of post-traumatic stress disorder: a systematic review and meta-analysis" Cambridge University Press (CUP) 26 (26): 338-344, 2021

18 Goracci A, "Practical guidance for prescribing trazodone extended-release in major depression" 17 : 433-441, 2016

19 Akira Kishimoto, "Post-traumatic Stress Disorder Symptoms in a Female Patient Following Repeated Teasing: Treatment with Gabapentin and Lamotrigine and the Possible Role of Sensitization" 대한정신약물학회 12 (12): 240-242, 2014

20 Carmassi C, "PTSD symptoms in healthcare workers facing the three coronavirus outbreaks : what can we expect after the COVID-19 pandemic" 292 : 113312-, 2020

21 Guina J, "PTSD symptom severities, interpersonal traumas, and benzodiazepines are associated with substance-related problems in trauma patients" 5 : 70-, 2016

22 Raudenská J, "Occupational burnout syndrome and post-traumatic stress among healthcare professionals during the novel coronavirus disease 2019(COVID-19)pandemic" 34 : 553-560, 2020

23 Ransing R, "Mental health interventions during the COVID-19 pandemic : a conceptual framework by early career psychiatrists" 51 : 102085-, 2020

24 Ransing R, "Infectious disease outbreak related stigma and discrimination during the COVID-19 pandemic : drivers, facilitators, manifestations, and outcomes across the world" 89 : 555-558, 2020

25 Sutherland ME, "Identifying treatment-resistant PTSD" 3 : 549-, 2019

26 Elaheh Haghgoshayie, "Healthcare workers are at risk of acute or post-traumatic stress and psychological distress during emerging virus outbreaks" BMJ 24 (24): 136-136, 2021

27 Adiukwu F, "Global perspective and ways to combat stigma associated with COVID-19" 42 : 569-574, 2020

28 MacNamara A, "Emotion regulatory brain function and SSRI treatment in PTSD : neural correlates and predictors of change" 41 : 611-618, 2016

29 Vgontzas AN, "Effects of trazodone versus cognitive behavioral therapy in the insomnia with short sleep duration phenotype : a preliminary study" 16 : 2009-2019, 2020

30 Montalbano A, "Dual inhibitory action of trazodone on dorsal raphe serotonergic neurons through 5-HT1A receptor partial agonism and α1-adrenoceptor antagonism" 14 : e0222855-, 2019

31 Claudia Carmassi, "Defining effective strategies to prevent post-traumatic stress in healthcare emergency workers facing the COVID-19 pandemic in Italy" Cambridge University Press (CUP) 26 (26): 553-554, 2021

32 배성만, "Comparison of Memory Function and MMPI-2 Profile between Post-traumatic Stress Disorder and Adjustment Disorder after a Traffic Accident" 대한정신약물학회 12 (12): 41-47, 2014

33 Cuomo A, "Clinical guidance for the use of trazodone in major depressive disorder and concomitant conditions : pharmacology and clinical practice" 54 : 137-149, 2019

34 Ransing R, "Can COVID-19 related mental health issues be measured?" 88 : 32-34, 2020

35 Adiukwu F, "COVID-19 mental health care toolkit : an international collaborative effort by Early Career Psychiatrists section" 33 : e100270-, 2020

36 Pereira-Sanchez V, "COVID-19 effect on mental health : patients and workforce" 7 : e29-, 2020

37 Riley DS, "CARE guidelines for case reports : explanation and elaboration document" 89 : 218-235, 2017

38 Guina J, "Benzodiazepines for PTSD : a systematic review and meta-analysis" 21 : 281-303, 2015

39 Gilbert M, "An emulation of randomized trials of administrating benzodiazepines in PTSD patients for outcomes of suicide-related events" 9 : 3492-, 2020

40 De Berardis D, "Alexithymia, suicide ideation, affective temperaments and homocysteine levels in drug naïve patients with post-traumatic stress disorder : an exploratory study in the everyday ‘real world’ clinical practice" 24 : 83-87, 2020

41 Hoffelt C, "A review of significant pharmacokinetic drug interactions with antidepressants and their management" 6 : 35-41, 2016

42 Fagiolini A, "A randomized, double-blind study comparing the efficacy and safety of trazodone once-a-day and venlafaxine extended-release for the treatment of patients with major depressive disorder" 35 : 137-146, 2020